Authors
Latest:
EyeCon 2024: Insights on transforming ocular surface disease managementPeter J. McDonnell, MD, and Laura M. Periman, MD, discussed innovations in treating ocular surface conditions, emphasizing patient-centered care and interdisciplinary collaboration.
Latest:
AOA 2023: Integrating vision rehabilitation into primary care optometryJanis Winters, OD, FAAO, shares insights from her case study that she copresented during the 2023 AOA Optometry's Meeting in Washington, DC.
Latest:
AAOpt 2023: Dr Karen Carrasquillo gives highlights of the presentations she was part of during AcademyKaren G. Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, shares highlights from her 2023 AAOpt presentations on scleral lenses, as well as cultural competency.
Latest:
EVO ICL may be best-kept secret in refractive surgeryAs demand for this lens grows, the need for expert refractive comanagement will expand as well.
Latest:
ASCRS 2023: The safety of office space cataract surgeriesLance Kugler, MD, recapped his presentation and findings on the safety of office space cataract surgery with the Ophthalmology Times© team at the ASCRS annual meeting in San Diego.
Latest:
VEW 2024: The Vision Expo experience and looking ahead to Orlando in 2025Dr. Kristie Nguyen shares her favorite parts of Vision Expo West 2024 and shares her excitement for the relocation of Vision Expo East for 2025.
Latest:
New data in anterior segment laser surgeryResearch provides insight into selective trabeculoplasty, YAG capsulotomy, peripheral iridotomy
Latest:
Keep your contact lens practice on the cutting edgeFitting the right lens requires a detective's mindset.
Latest:
ARVO 2024: Evaluating in-home use of novel contact lens solution in potential lens dropoutsMarjorie Rah, OD, PhD, FAAO, discussed the in-home use test of BioTrue Hydration Plus multipurpose contact lens solution (Bausch + Lomb) on patients who are considering lens dropout.
Latest:
Achieving improved outcomes through partnerships between optometrists and retina specialistsConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
SECO 2023: Pipeline update from TarsusTarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.
Latest:
Which myopia treatment works best?Exploring myopia control treatment efficacy does not demand clinical complexity.
Latest:
A case-based, comprehensive overview of pediatric conditions, treatment optionsKatie Connolly, OD, shares about her presentation, “Therapeutics for Pediatrics: Just Say Yes,” which she presented during the 2022 AOA Optometry’s Meeting in Chicago.
Latest:
AOA 2023: Understanding and applying different angiographyJessica Haynes, OD, shares highlights from her 2023 AOA Optometry's Meeting presentation, "Application of angiography."
Latest:
Review Duane’s retraction syndrome diagnosis and treatmentUnderstand the condition’s structural, innervational, neurological, and genetic abnormalities
Latest:
How those with low vision, blindness can utilize the ARx AI headsetCharles Leclercq, CEO of ARxVision, outlines the conception of ARxVIsion's collaboration with Seeing AI and NaviLens apps, and details the popular uses for the headset so far.
Latest:
Furthering the adoption of myopia management in Latin AmericaRicardo Pintor, OD, FIACLE, gives an overview of the World Council of Optometry’s first Latin America–based virtual event and what challenges Latin America faces in terms of myopia.
Latest:
International Keratoconus Academy of Eye Care Professionals: A historical perspectiveThe collective enhances education, research, and quality of life.
Latest:
AOA 2023: Uniting the OD and MD perspectives on keratoconus and crosslinkingAt the AOA Optometry's Meeting 2023, Jonathan Etter, MD, FAAO, presented with Susan Gromacki, OD, MS, FAAO, FSLS, on the OD and MD perspectives on keratoconus and collagen crosslinking.
Latest:
Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopiaAn inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.
Latest:
Welcoming myopia modalities into optometric practiceIncorporate management of disease as the new standard of care.
Latest:
Adherence and persistence: When patients take their health into their own handsBoth are critical to successful treatment, but how can optometrists help?
Latest:
AOA 2024: Uncovering the ocular connection in neurodegenerative diseasesDrs Erin Draper and Christopher Kuc reiterate the important role optometrists play in identifying biomarkers for neurodegenerative diseases in patients.
Latest:
The evolving relationship between optometrists and ophthalmologists: Enhancing patient care through collaborationKhanh Hoang, OD, details how comanagement relationships can be streamlined for the benefit of the patient.
Latest:
FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopiaQlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Latest:
EnVision Summit 2025: What you missed in keratoconus, AI, and comanagementThree EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Latest:
That’s not AMD: Mimickers of age-related macular degenerationFrom Stargardt to macular telangiectasia type 2, Kensington Hatcher, OD, FAAO, FORS; and Srinivas Kondapalli, MD, detail other conditions that share similarities to AMD.
